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Abstract
Background: Recently, HVBP has been a tool for improving the quality of healthcare services and managing costs. This study was
conducted to identify and propose an appropriate model of HVBP in the general selected teaching hospitals in Isfahan, Iran.
Objectives: The purpose of this study was to propose an Iranian model of HVBP in the selected teaching hospitals in Isfahan, Iran,
2015 - 16.
Methods: This study was a theoretical and qualitative study. It was cross-sectional and prospective in terms of time, direction, and
trend. The sample was determined purposefully in Delphi methods. Three types of Delphi methods were conducted including:
theory, policy, and implementation Delphi. The sample size in Delphi methods respectively included 9, 13, and 21 that were selected
in type of experts sampling and cascading in 2015 - 16. Inclusion and exclusion criteria were designated to select sample in all three
types of Delphi methods.
Results: According to the results of the study, the proposed Iranian model of HVBP had seven dimensions including structure,
process, outcome, patient experience, quality of clinical care, sensitivity of care team, and efficiency with the weight percentages of
5, 5, 25, 20, 15, 15, and 15, respectively. Each of the dimensions had 5, 6, 5, 7, 5, 4, and 1 components/component, respectively.
Conclusions: This study identified and proposed a model of HVBP in the Isfahan selected general teaching hospitals. The practi-
cal application of the findings was to determine the dimensions and components of HVBP in Isfahan general teaching hospitals.
According to the findings of this study, it is suggested that a series of related research be conducted to complete the identification
process of HVBP in Iran in other types of hospital settings.
Keywords: Value-Based Purchasing (VBP), Hospital Value-Based Purchasing (HVBP), Model, Pay for Performance (P4P), Insurance,
Delphi Methods
1. Background
Healthcare purchasing plays a vital role in the health-
care financing (1, 2). One of the most important purchasing
types recently introduced is VBP (3-5). VBP is a payment sys-
tem that holds providers accountable for both the quality
and cost of healthcare that they supply; therefore, it links
payments with improved performance by healthcare ser-
vices providers (6-8). HVBP is a type of VBP in inpatient hos-
pital settings, used as a tool for improving the quality of
care and a reasonable cost reduction, and it is considered a
type of P4P (6, 9). Health insurance systems, such as Medi-
care, have developed plans and models for purchasing the
required inpatient care and healthcare services with the
desired quality and the lowest cost (6, 10). HVBP has been
used for the first time by the CMS in the United States (9,
10).
Recent reforms in the healthcare financing systems
have led to purchaser and provider split and rethinking
in purchasing functions from inactive to active and strate-
gic purchasing (11). In the report of WHO in 2010 it has
been expressed that healthcare purchasing should move
from inactive to active and strategic approach (12). Since
purchasing plays a decisive role in improving quality and
costs, health care systems in the world have recently used
it as a topic for reforms (12, 13). However, there are several
basic approaches for modeling of purchasing and improv-
ing the quality of hospital services (14, 15). In Canada, the
quality of each hospital will be evaluated and purchased
using the hospital health service quality indicators and
data collection from the CIHI (16). In the United States,
the high quality of hospital care will be purchased using
VBP programs and models, along with a positive incen-
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tive approach through a bonus payment system (5). In the
UK and Germany, the healthcare is purchased by adopt-
ing a negative incentive approach, through the payment
system, for example, non-payment of hospital fees in re-
hospitalization (6, 17). The HVBP in services and inpatient
care has undergone continuous changes over recent years,
as the latest editions in 2015 (10) comprised a review of four
essential dimensions of hospital services, which included:
quality of clinical care, patient experience, outcome, and
efficiency (18). Each of these four dimensions has criteria
and sub-criteria for measurement, and combination ad-
just marker is used to measure some of them (9, 10, 18, 19).
In Iran healthcare system, purchasers of inpatient care
and hospital services, including basic insurer organiza-
tions, purchase hospital care using inactive purchasing
strategies (1, 20). Although recently, purchasing has strate-
gic, operational, and organizational goals in the IHIO, the
continuing inactive purchasing of services has led to major
problems, such as reduced quality of clinical services and
performance, weak outcomes of care and consequently,
low satisfaction level of patients and hospital care users
(20-23).
Recent research has shown that lack of HVBP model
or inactive purchasing may cause problems in inpatient
care of Iran (1, 20, 23-25), such as inappropriate or incor-
rect diagnosis, treatment, and rehabilitation of patients in
the inpatient care, incomplete treatments, injury to the pa-
tient due to error and mistakes in the hospital care, un-
certainty and not involvement of the patient in choosing
a care method (including diagnosis and treatment meth-
ods), low efficiency of the system in providing hospital ser-
vices, and weak outcome rates for diagnosis and treatment
in medical and nursing services (20, 21, 23, 26). In contrast,
HVBP model has increased the quality of care and reduced
costs by linking payments to acceptable performance (6, 9,
10, 19). Studies conducted in the US health system have in-
dicated a very high effect of the inpatient care purchasing
strategy type on the quality of care (6, 10, 27, 28).
One of the main obstacles to quality development and
cost management in inpatient care is the lack of model-
ing of HVBP in Iran. Not only the payment system for in-
patient care provided by Iran medical insurance agencies
has not improved quality and reduced medical errors in
the health care system (20, 21, 23), but also in the reform of
Iran’s health system, implemented since the second half of
2014, no goal or program has been allocated to VBP or HVBP
(29).
In Iran, most studies in the field of inpatient care have
only focused on measuring quality indicators of care in
accreditation and not on the value-based purchasing (30,
31). It seems that conducting a study for HVBP modeling in
Iran hospital settings may be useful to prevent major cur-
rent problems existed in inpatient care purchasing and it
could be creative for value-based purchasing in the hospi-
tal care system. Therefore, this study aimed to identify and
propose the HVBP model in Isfahan selected general teach-
ing hospitals in 2015 - 16, and attempted to develop a func-
tional and applicable model to improve the quality and re-
duce the cost of hospital care by linking payment to perfor-
mance and creation of the value.
2. Methods
Qualitative methods could be more useful for identify-
ing and characterizing comparative studies. This research
was a theoretical and qualitative study, and it was cross-
sectional and prospective in terms of time, direction, and
trend. The sample in this study was purposefully deter-
mined in the type of expert sampling in the last month of
2015 and the first month of 2016 in Isfahan teaching hospi-
tals, Iran. The inclusion criteria for the selected sample of
all three types of Delphi methods (theory, policy, and im-
plementation Delphi’s) included:
- Having related experience in healthcare purchasing
studies background (for theory Delphi), and at least three
years of related experience in healthcare purchasing back-
ground and experience for managers and decision-makers
of the IHIO and the general directorate and the staff of the
general health Insurance department in Isfahan, and the
same experience for the executives of Isfahan university of
medical sciences (for Policy Delphi); and three years of im-
plementation experience in hospital, for bosses and man-
agers in selected samples of the hospitals (in implementa-
tion Delphi)
- Familiarity with value-based purchasing and related
topics
- Being interested and having enough motivation to
collaborate in research and Delphi
The exclusion criteria consisted of those individuals
who had not sufficient information about the subject or
were not willingness to be in Delphi. In the qualitative
stage of the study, i.e. the Delphi methods, the number of
respondents at the levels of implementation, policy, and
theory Delphi were 21, 13, and 9, respectively. As mentioned
before, sample selection was purposefully in the type of ex-
pert sampling and cascade form. Other features of the re-
spondents and expert target groups are listed in Table 1.
This study was conducted in two independent stages
including theoretical study and cascade Delphi methods.
As a basis for the current study, Delphi method was used for
qualitative research. It is an exploratory method to identify
the nature and fundamental elements of a phenomenon
(the HVBP model). It is a structured process for collect-
ing data during successive rounds and group consensus.
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Table 1. Respondent Characteristics Based on Levels of Delphi Methods
Sample levels in Delphi Methods
Delphi at Implementation
Level
Delphi at Policy Level Delphi at Theory Level
Selected Sample Features Number 21 13 9
Target group (Experts) Bosses, Managers, Doctors, and
Nurses
- Managers of the Ministry of
Health and Medical Education
in Tehran, and Isfahan
University of Medical Sciences
(in related fields).
- Isfahan University of Medical
Sciences, Iran
- Insurance directors at the
Ministry of Welfare (Tehran
Health and Safety Insurance)
- Tehran University of Medical
Sciences, Iran
- Managers of the General
Directorate of Health Insurance
and Social Security of Isfahan
Province
- Iran University of Medical
Sciences, Iran
- Maryland University of
Medical Sciences, United States
- Harvard and Brandis
University, United States
Age, mean 47.2 48.6 51.3
Sex
Male 13 11 7
Female 8 2 2
Location Sample composition 7 people from each hospital,
and in total, three teaching
hospitals in Isfahan (21), Iran
5 people in Isfahan province
and 8 people in Tehran, Iran
From each university, one
person other than the
universities of Isfahan and Iran,
each of whom had three faculty
members
This method was used in three types, including theoretical,
implementation, and policy Delphi. Delphi methods were
used to identify and evaluate the model from the aspects
of theoretical, implementation, and policy.
In the first stage, a theoretical study (literature review)
was conducted regarding the issue of hospital value-based
purchasing in different countries. The results of the first
stage on all types of HVBP conditions in the world were
used to develop a structured and summarized draft for the
Delphi questionnaire. Therefore, the Delphi preliminary
questionnaire was created by using the conceptual frame-
work of the first phase and literature review.
In the second stage of the study, Delphi methods were
conducted in 3 rounds and the responders were asked to
choose the appropriate dimensions and components for
an Iranian model of HVBP, according to the findings of the
worldwide studies and the existed conditions and to make
comments/suggestions for each question. As mentioned,
in the second stage, the Delphi methods were conducted to
identify and evaluate the model in accordance with theory,
policy, and implementation agreement and group consen-
sus. The way of using the Delphi methods in this study is
shown in Figure 1.
In this study, the Delphi preliminary questionnaire was
made thorough literature review (the first stage) for using
as the data collection tool. Data analysis was conducted
using the Delphi method in 3 rounds and in accordance
with the process shown in Figure 1, which had four stages.
The data analysis revealed dimensions (main constraints),
their weight, and related components of the model. Eth-
ical considerations were observed during data collection
and analysis using the Delphi rounds.
3. Results
The findings of the three rounds of Delphi methods are
presented in the following tables. According to the results
of the first stage of this study in theoretical section (liter-
ature review), there were three types of known HVBP. The
American model of HVBP, in 2015 - 16, had four dimensions
(18), the UK (NHS) model had five dimensions (32), and the
German model had three dimensions (33). The proposed
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Yes Yes 
Yes 
No No 
No 
No 
Yes 
Delphi Phase I-Determining the
dimensions, components and
weights of each dimensions of the
"Hospital Value-based Purchasing"
Model, in the selected teaching
hospitals of Isfahan, Iran, based on
existing models from the
theoretical study result (literature
reviews) that used in phase 1 of the
Delphi, for the preliminary
questionnaire. This Delphi phase
consisted of three expert groups:
the first group included: experts
(theoretically evaluation), the
second group included: policy
makers of the Ministries of Health,
Welfare, and Iran Health Insurance
Organizations (for evaluation of
policy), the third group included:
hospital managers, doctors, nurses
(for evaluation of implementation)
Matching the comments of the three groups (in
the three aspects of theory, policy, and
implementation) on the dimensions,
components of the proper model for Iran
Final phase of Delphi - Is
the model confirmed finally
by all three groups (in
conformance of the theory,
policy, and
implementation)?
Third phase of Delphi -
Determining the functionality
of the Value-Based Purchasing
Model by evaluation of
implementers’ comments - Is
the Model confirmed for
Implementation by the
Implementer Team (Third
Group)?
Second phase of Delphi -
Determining policy capacity,
in the Hospital Value-Based
purchasing Model, Is the
Model confirmed by
policymakers of Health,
Welfare Ministries and IHIO
for policy evaluation (Second
Group)?
Were the dimensions and
components the same on the
basis of the designated
models, in the theoretical
study (literature reviews)
and according to experts
comments (first group) and
was there consensus?
Figure 1. Flowchart of the Delphi Methods
Iranian model, which is identified by Delphi, had 7 dimen-
sions, as follows:
3.1. Dimensions of the HVBP Model
Based on the value of the weight of Delphi findings,
presented in Table 2; the dimensions of the Iranian HVBP
model included:
Table 2. The Dimensions of the Iranian Hospital Value-Based Purchasing Model
N Dimensions Dimensional Weight, %
1 Structural variable 5
2 Process variable 5
3 Outcome variable 25
4 Patient Experience variable 20
5 Quality of Clinical care variable 15
6 Sensitivity of care team variable 15
7 Efficiency variable 15
Total 100
3.2. The Components of Each Dimension of the Iranian HVBP
Model
The Delphi findings are shown in Table 3. The compo-
nents of the Iranian HVBP model included:
3.3. Considering the Dimensions and Components of the Model
The proposed VBP model (HVBP) for Iran is presented
as follows (Figure 2):
4. Discussion and Conclusion
The main goal of the current study was to determine
the HVBP model in Isfahan selected general teaching hos-
pitals in 2015 - 16. The study identified 7 dimensions for
the HVBP model and 33 components. As the results of the
study showed, an important dimension for the identified
model was quality of clinical care that included the com-
ponents or measures such as acute myocardial infarction
(AMI), heart failure (HF), pneumonia (PN), surgical care im-
provement project (SCIP), and Healthcare Associated infec-
tions (HAI), similar to the HVBP model in the US (18, 34-37).
As literature review of this study indicated, VBP, which
is used as a strategy for improving quality of healthcare
services and cost control (38), in health insurance sys-
tems is usually in three types (39): Beveridge (British na-
tional health system), Bismarck (German insurance sys-
tem), and more in the Medicare insurance system in the
United States. In the following, the results of this study are
compared with the mentioned models.
As outlined in the results section, seven dimensions of
the HVBP model included structural, process, outcome, pa-
tient experience, quality of clinical care, sensitivity of care
team, and efficiency in acute care in selected teaching hos-
pitals. The dimensions of this model were similar to those
of the US model (18), in terms of quality of care, patient ex-
perience, and outcomes, while in the three dimensions of
structure, process, and sensitivity of care team our model
was different from the US model.
In the United States, with the creation of new payment
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Table 3. The Components of the Iranian Hospital Value-Based Purchasing Model
Dimensions 1 2 3 4 5 6 7
Structure Process Outcome Patient
Experience
Quality of
Clinical care
Sensitivity of
care team
Efficiency
Components
- Scientific
information and
evidence
(Standard
Clinical
Protocols and
guidelines)
- Process of
performance in
clinical ward
- Outcome of
acute
myocardial
infarction
- Patient
relationship
with nurses
- Acute
Myocardial
Infarction (AMI)
- Sensitivity of
nursing care
Key Efficiency
Indicators for
Health and
Medical
Insurance
- Education - Process of care
communication
and information
- Outcome of
pneumonia
- Patient
relationship
with doctors
- Heart Failure
(HF)
- Nursing
workplace
Satisfaction
questionnaire
- Experience - Process of
patient safety
- Outcome of
heart failure
- Responsibility
of hospital staff
- Pneumonia
(PN)
- Satisfaction of
the patient with
nursing and
medical care
- Exclusive
scientific
evidence and
creative
technology
- Process of the
care team safety
- Outcome of
central Line
Infection
- Pain
management
comfort of the
hospital
environment
- Surgical Care
Improvement
Project (SCIP)
- Key sensitivity
analysis
compared to the
regional
national
benchmark
- Technology and
equipment
- Process of the
care
documentation
- Outcome of
patient safety
- Pharmaceutical
relationship
- Healthcare
Associated
infections (HAI)
- Process of care
planning and
management
- Clearance
information
Iranian Model of 
Hospital Value-
Based Purchasing 
P1
P2
Structure (S)
Process (P)
Sensitivityofcareteam (SCT)
Quality of Clinical care (QCC)
Efficiency 
Outcome(0)
Patient Experience (PE) 
Figure 2. The Proposed Model for Iran Hospital Value-Based Purchasing (IHVBP) - Based on Delphi Findings
models and alternatives, the payment system has been
changed from retrospective, volumetric, quantitative or
pay for services (FFS) to prospective, qualitative and value-
based payments (18, 35, 40-46). The HVBP is computed us-
ing the following four dimensions (9, 18, 34, 37, 47, 48):
- Quality of the clinical care (Q),
- Patient Experience (PE)
- Outcome (O)
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- Efficiency (E)
In the US model of HVBP, the weights of the HVBP di-
mensions are expressed in terms of TPS (4, 18, 37, 48). TPS in
VBP is calculated based on four dimensions including qual-
ity of clinical care 20%, patient experience 30%, outcome
30%, and efficiency 20% of TPS in 2016 - 2017 (18, 37, 48-50):
(E) 20% + (O) 30% + (PE) 30% + (Q) 20% = TPS
The identified model in this study had different
weights compared to the US model, but concerning the
weights of dimensions in the both, the highest weight in
both models was on outcome.
In a survey, a VBP model in the UK national medical sys-
tem had largely 5 dimensions, which was included in the
5-year medium-term contracts (51). The identified model
in this study was 7-dimensional and had two common di-
mensions, namely patient outcomes and quality of clinical
care, with the model of NHS while it had 5 different nomi-
nal dimensions, but relatively similar in reality (52).
In the NHS of the United Kingdom, value-based pur-
chasing is included in the conclusion of contracts for pur-
chasing hospital care in five years. For example, in NHS
BCCG and in musculoskeletal care, for a five-year contract
concluded in this regard, the payment system had two
parts: a fixed part (Bundled payment), in which the total
amount is reduced from 97.7% to 80% for the whole five
years of the contract in a descending trend, and a variable
part (outcomes-based payment), which changes from 2.5%
to 20% in a total of five years of the contract during these
five years in an ascending trend (51, 52). The dimensions
used in calculating the financial incentive of VBP included
(52):
- Innovative use of technology (T)
- Continuous and exclusive care (I)
- Improved patient outcomes (O)
- Patient experience quality (E)
- Published annual report (AR)
The amount of financial incentive is calculated in each
season, using the following formula (51):
Financial incentive = 20% (T) + 20% (I) + 30% (O) + 20%
(E) + 10% (AR)
The results of this study had similarities with the Ger-
man model of VBP, in three structural, process, and out-
come dimensions, and had a nominal difference in other
four dimensions. However, the HVBP is very new in both
countries, and the both models focus on outcomes (The
highest weight in both models was on outcome.)
In the German health system, the following dimen-
sions have been considered in traditional VBP (33, 38, 53):
- Cost and efficiency of healthcare providing (C)
- Hospital efficacy status, with considering the integra-
tion status (E)
- Effective and value-added clinical path, approved by
the sub committee of values (CP)
- Effective medicine and technology (T)
- Quality management system (QMS)
- Structural measures (S)
- Process and care measures (P)
- Quality outcome measures (O)
In this review, there was no specific formula for VBP, al-
though the German system followed the European quality
management system (33). The German model of HVBP is
based on the quality management model and it is based
on the three structural, processes, and outcome dimen-
sions that these dimensions are common with the result-
ing model in this study.
Germany has one of the oldest national health systems.
In the last 15 years, a new health system infrastructure has
been evaluated for value-based, which included medicines,
treatments, and health care pathways, and focused on the
outcomes and accepted them as indicators (33, 38).
In Germany, health technology assessment methods, a
lot of emphasis on cost savings, and the pharmaceutical in-
dustry were issues that related to VBP (54). In general, re-
cent reforms in the German health system in relation to
VBP included (33) the 2000 reform and diagnostic reim-
bursement groups DRG system and quality management
system introduced in the same year. In the 2005 reform,
laws were passed, which considered the quality of provid-
ing care and services in terms of structural measures, such
as diagnostic devices, workforce numbers and skills, and
care processes. In 2007, hospitals were required to present
a limited report on the final quality implications.
In this study, the dimensions of the identified model
have similarities and differences with others in different
health (insurance) systems, but in all models of HVBP, the
emphasis was on the outcome and it was the most impor-
tant dimension that had the highest weight.
This study identified and proposed a model of HVBP in
the Isfahan selected general teaching hospitals. The practi-
cal application of the findings was to determine the dimen-
sions and components of HVBP in Isfahan general teach-
ing hospitals. According to the findings of this study, it is
suggested that a series of related research be conducted
to complete the identification process of HVBP in Iran and
then to begin the solving process of healthcare purchasing
problems in Iran. In this regard, studies are recommended
to identify dimensions and components of HVBP in other
hospital settings in Iran.
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